These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 33452680)
41. The calcium-sensing receptor in bone metabolism: from bench to bedside and back. Cianferotti L; Gomes AR; Fabbri S; Tanini A; Brandi ML Osteoporos Int; 2015 Aug; 26(8):2055-71. PubMed ID: 26100412 [TBL] [Abstract][Full Text] [Related]
42. Autophagy in Bone Remodeling: A Regulator of Oxidative Stress. Zhu C; Shen S; Zhang S; Huang M; Zhang L; Chen X Front Endocrinol (Lausanne); 2022; 13():898634. PubMed ID: 35846332 [TBL] [Abstract][Full Text] [Related]
43. Treatment of Paget's disease of bone with porcine calcitonin. Eisman JA; Xipell JM; Sloman JG; Jerums G; Martin TJ Med J Aust; 1974 Apr; 1(15):564-8. PubMed ID: 4858264 [No Abstract] [Full Text] [Related]
44. Mathematical model predicts a critical role for osteoclast autocrine regulation in the control of bone remodeling. Komarova SV; Smith RJ; Dixon SJ; Sims SM; Wahl LM Bone; 2003 Aug; 33(2):206-15. PubMed ID: 14499354 [TBL] [Abstract][Full Text] [Related]
45. The effects of fluoride therapy on metabolic bone disease. A histologic study. Baylink DJ; Bernstein DS Clin Orthop Relat Res; 1967; 55():51-85. PubMed ID: 6079753 [No Abstract] [Full Text] [Related]
46. Recent insights into the biology of bone turnover. Riches PL; Ralston SH J R Coll Physicians Edinb; 2010 Mar; 40(1):66-9. PubMed ID: 21125043 [No Abstract] [Full Text] [Related]
48. Quantitative bone histology in Paget's disease of bone: influence of sodium etidronate (EHDP) therapy. Khairi MR; Meunier P; Edouard C; Courpron P; Bernard J; DeRosa GP; Johnston CC Calcif Tissue Res; 1977 May; 22 Suppl():355-8. PubMed ID: 410484 [No Abstract] [Full Text] [Related]
49. Paget's disease. Common cause of bone weakening. Mayo Clin Health Lett; 2013 Jun; 31(6):7. PubMed ID: 24716278 [No Abstract] [Full Text] [Related]
50. Autophagy: a new player in skeletal maintenance? Hocking LJ; Whitehouse C; Helfrich MH J Bone Miner Res; 2012 Jul; 27(7):1439-47. PubMed ID: 22706899 [TBL] [Abstract][Full Text] [Related]
51. Bone hypertrophy and trabecular generation in Paget's disease and in fluoride-treated osteoporosis. Aaron JE; de Vernejoul MC; Kanis JA Bone Miner; 1992 Jun; 17(3):399-413. PubMed ID: 1623333 [TBL] [Abstract][Full Text] [Related]
52. Mechanisms of autophagy and mitophagy in skeletal development, diseases and therapeutics. Behera J; Ison J; Tyagi A; Mbalaviele G; Tyagi N Life Sci; 2022 Jul; 301():120595. PubMed ID: 35504330 [TBL] [Abstract][Full Text] [Related]
53. Autophagy plays an essential role in bone homeostasis. Jaber FA; Khan NM; Ansari MY; Al-Adlaan AA; Hussein NJ; Safadi FF J Cell Physiol; 2019 Aug; 234(8):12105-12115. PubMed ID: 30820954 [TBL] [Abstract][Full Text] [Related]
54. The Potential of Natural Compounds Regulating Autophagy in the Treatment of Osteoporosis. Zhao Y; Qu Z; Zhao S; Zhang Y; Gong Y; Zhang B; Gao X; Wang D; Yan L J Inflamm Res; 2023; 16():6003-6021. PubMed ID: 38088943 [TBL] [Abstract][Full Text] [Related]
55. Osteoblasts and osteoclasts in bone marrow aspiration; previously undescribed cell findings in Paget's disease (osteitis deformans). RUBINSTEIN MA; SMELIN A; FREEDMAN AL AMA Arch Intern Med; 1953 Nov; 92(5):684-96. PubMed ID: 13091485 [No Abstract] [Full Text] [Related]
56. Arthritis in Paget's disease of bone. Altman RD J Bone Miner Res; 1999 Oct; 14 Suppl 2():85-7. PubMed ID: 10510220 [No Abstract] [Full Text] [Related]
57. [Comparison of the histology and kinetics of radiocalcium in Paget's disease]. Caniggia A; Gennari C Boll Soc Ital Biol Sper; 1973 Jul; 49(12):738-40. PubMed ID: 4791317 [No Abstract] [Full Text] [Related]
58. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP). Rashid M; Khairi A; Johnston C Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576 [No Abstract] [Full Text] [Related]
59. [Mechanisms of action of anticatabolic drugs used in osteoporosis therapy]. Kryśkiewicz E; Lorenc RS Endokrynol Pol; 2009; 60(2):134-44. PubMed ID: 19396757 [TBL] [Abstract][Full Text] [Related]
60. Osteoblast as a target of anti-osteoporotic treatment. Corrado A; Sanpaolo ER; Di Bello S; Cantatore FP Postgrad Med; 2017 Nov; 129(8):858-865. PubMed ID: 28770650 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]